Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Characterization of Spray-Dried Powders Using a Coated Alberta Idealized Nasal Inlet.
Duong K, Aisenstat M, Chen JZ, Murphy B, Tavernini S, Wang H, Reiz B, Zheng J, Whittal R, McClary WD, Gerhardt A, Fox CB, Finlay WH, Vehring R, Martin AR. Duong K, et al. Among authors: fox cb. J Aerosol Med Pulm Drug Deliv. 2025 Jan 13. doi: 10.1089/jamp.2024.0029. Online ahead of print. J Aerosol Med Pulm Drug Deliv. 2025. PMID: 39804033
Optimizing immunogenicity and product presentation of a SARS-CoV-2 subunit vaccine composition: effects of delivery route, heterologous regimens with self-amplifying RNA vaccines, and lyophilization.
Lykins WR, Pollet J, White JA, Keegan B, Versteeg L, Strych U, Chen WH, Mohamath R, Ramer-Denisoff G, Reed S, Renshaw C, Beaver S, Gerhardt A, Voigt EA, Tomai MA, Sitrin R, Choy RKM, Cassels FJ, Hotez PJ, Bottazzi ME, Fox CB. Lykins WR, et al. Among authors: fox cb. Front Immunol. 2024 Dec 16;15:1480976. doi: 10.3389/fimmu.2024.1480976. eCollection 2024. Front Immunol. 2024. PMID: 39737197 Free PMC article.
Exploring yeast glucans for vaccine enhancement: Sustainable strategies for overcoming adjuvant challenges in a SARS-CoV-2 model.
Azevedo-Silva J, Amorim M, Tavares-Valente D, Sousa P, Mohamath R, Voigt EA, Guderian JA, Kinsey R, Viana S, Reis F, Pintado ME, Paddon CJ, Fox CB, Fernandes JC. Azevedo-Silva J, et al. Among authors: fox cb. Eur J Pharm Biopharm. 2024 Dec;205:114538. doi: 10.1016/j.ejpb.2024.114538. Epub 2024 Oct 24. Eur J Pharm Biopharm. 2024. PMID: 39461571 Free article.
Immunogenicity and safety of an Entamoeba histolytica adjuvanted protein vaccine candidate (LecA+GLA-3M-052 liposomes) in rhesus macaques.
Abhyankar MM, Xu F, Chavez D, Goodroe A, Mendoza E, Chen C, Singh DK, Varnador F Jr, Sivananthan SJ, Kinsey R, Lykins WR, Murphy BM, Martin AR, Tomai MA, Ghosal S, Casper C, Pedersen K, Petri WA Jr, Fox CB. Abhyankar MM, et al. Among authors: fox cb. Hum Vaccin Immunother. 2024 Dec 31;20(1):2374147. doi: 10.1080/21645515.2024.2374147. Epub 2024 Aug 1. Hum Vaccin Immunother. 2024. PMID: 39090779 Free PMC article.
A comparative immunological assessment of multiple clinical-stage adjuvants for the R21 malaria vaccine in nonhuman primates.
Arunachalam PS, Ha N, Dennison SM, Spreng RL, Seaton KE, Xiao P, Feng Y, Zarnitsyna VI, Kazmin D, Hu M, Santagata JM, Xie X, Rogers K, Shirreff LM, Chottin C, Spencer AJ, Dutta S, Prieto K, Julien JP, Tomai M, Fox CB, Villinger F, Hill AVS, Tomaras GD, Pulendran B. Arunachalam PS, et al. Among authors: fox cb. Sci Transl Med. 2024 Jul 31;16(758):eadn6605. doi: 10.1126/scitranslmed.adn6605. Epub 2024 Jul 31. Sci Transl Med. 2024. PMID: 39083589
From hit to vial: Precision discovery and development of an imidazopyrimidine TLR7/8 agonist adjuvant formulation.
Soni D, Borriello F, Scott DA, Feru F, DeLeon M, Brightman SE, Cheng WK, Melhem G, Smith JA, Ramirez JC, Barman S, Cameron M, Kelly A, Walker K, Nanishi E, van Haren SD, Phan T, Qi Y, Kinsey R, Raczy MM, Ozonoff A, Pettengill MA, Hubbell JA, Fox CB, Dowling DJ, Levy O. Soni D, et al. Among authors: fox cb. Sci Adv. 2024 Jul 5;10(27):eadg3747. doi: 10.1126/sciadv.adg3747. Epub 2024 Jul 3. Sci Adv. 2024. PMID: 38959314 Free PMC article.
159 results